Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nondisjunction

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...

Nondisjunction

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.

Nondisjunction

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

Purpose of Health Records II

Purpose of Health Records II

Health records serve various essential purposes in the healthcare system. Here are some key purposes:

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

The Cochrane database of systematic reviews·2022

Same author

Population-Based Surveillance of Birth Defects Potentially Related to Zika Virus Infection - 15 States and U.S. Territories, 2016.

MMWR. Morbidity and mortality weekly report·2018

Same author

A quality assessment of reporting sources for microcephaly in Utah, 2003 to 2013.

Birth defects research. Part A, Clinical and molecular teratology·2016

Same author

Population-based birth defects data in the United States, 2008 to 2012: Presentation of state-specific data and descriptive brief on variability of prevalence.

Birth defects research. Part A, Clinical and molecular teratology·2015

Same author

Development and implementation of the first national data quality standards for population-based birth defects surveillance programs in the United States.

BMC public health·2015

Same author

Prevalence, Correlates, and Outcomes of Omphalocele in the United States, 1995-2005.

Obstetrics and gynecology·2015

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Testing Epithelial Permeability in Fetal Tissue-Derived Enteroids

Testing Epithelial Permeability in Fetal Tissue-Derived Enteroids

Published on: June 16, 2022

Birth defects interstate data exchange: a battle worth fighting?

Cynthia Cassell¹, Cara Mai, Russel Rickard

¹North Carolina Birth Defects Monitoring Program, State Center for Health Statistics, Division of Public Health, Raleigh, North Carolina, USA. cynthia.cassell@ncmail.net

Birth Defects Research. Part A, Clinical and Molecular Teratology

|November 9, 2007

Summary

This summary is machine-generated.

Few states have interstate birth defects data exchange agreements, impacting surveillance. Establishing these agreements, even with neighboring states, can significantly improve birth defect monitoring nationwide.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: Jul 10, 2026

Testing Epithelial Permeability in Fetal Tissue-Derived Enteroids

Testing Epithelial Permeability in Fetal Tissue-Derived Enteroids

Published on: June 16, 2022

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

Public Health
Epidemiology
Biostatistics

Background:

Effective birth defect surveillance requires including all children within a defined catchment area.
Limited understanding exists regarding the impact of lacking interstate data exchange on birth defect surveillance programs.

Purpose of the Study:

To assess the current status of interstate birth defect data exchange agreements.
To quantify the extent of resident births occurring in non-resident states.

Main Methods:

Surveys were distributed to U.S. population-based birth defect programs to identify existing data exchange agreements, barriers, and the impact of out-of-state births.
National Center for Health Statistics (NCHS) data from 2002 on live birth residency were analyzed to determine out-of-state birth frequencies.

Main Results:

Only 21% of responding states had existing interstate data exchange agreements for birth defect data.
53% of responding states planned to develop such agreements.
Actual percentages of resident out-of-state live births ranged from 0.16% to 11.51%, with potential for significant capture improvement through neighboring state data sharing.

Conclusions:

Interstate birth defect data exchange agreements are uncommon, despite all states having resident births occurring out-of-state.
Further data are needed to fully quantify the impact on state-based birth defect programs.
Establishing agreements with key neighboring states offers a practical approach to enhance national birth defect surveillance.